Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 24, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
Journal: NPJ breast cancer
Published: August 17, 2022
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study.
Journal: The Lancet. Oncology
Published: June 03, 2022
Author Correction: GWAS of thyroid stimulating hormone highlights the pleiotropic effects and inverse association with thyroid cancer.
Journal: Nature communications
Published: December 17, 2021
Assessing thyroid cancer risk using polygenic risk scores.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 06, 2020
GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer.
Journal: Nature communications
Published: November 07, 2019
Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 06, 2019
Corrigendum: Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis.
Journal: Nature genetics
Published: July 28, 2017
Spinal Cord Injury due to Tumour or Metastasis in Aragón, Northeastern Spain (1991-2008): Incidence, Time Trends, and Neurological Function.
Journal: BioMed research international
Published: March 30, 2017
Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies.
Journal: Oncology (Williston Park, N.Y.)
Published: December 18, 2016
Last Updated: 09/26/2026